Respiratory Pharmacology Flashcards
Difference between agonist and antagonist
-agonist= activates a receptor response
-antagonist= blocks a receptor response
Drugs that control airway inflammation
Corticosteroids
-supress inflammatory reactions that trigger bronchospasms, oedema and mucous hypersecretion
Corticosteroids
-do not alter ultimate course of disease
-used for patients with asthma or COPD
-USE: 2x a day
-andministered with tablets, nebuliser or inhaler
Corticosteroids side effects
-hoarseness and oral candidiasis
-inhaled corticosteroids predispose to cataracts, skIn bruising and osteoporosis
-systemic corticosteroids contribute to osteoporosis, diabetes, hypertension, muscle dysfunction and adrenal insufficiency
Implications of corticosteroids in PT
-pt to rinse mouth after taking the drug
-if pt is diagnosed with osteoporosis, take precaution with MCTT
Drugs that facilitate airway bronchodilation
-B2-agonst bronchodilators
-anticholinergic bronchodilators
-xanthines
B2-agonist bronchodilators
-stimulate B2-receptors in bronchial smooth muscle
-onset=7min
-peak effect=20min
duraction of action=4-7hrs
-only provides symptomatic relief
there is short-acting and long-acting
administered with inhaler or nebuliser
iImplications of B2-agonists for PT
-tremor, tachycardia and agitation
Anticholinergic bronchodilator
-blocks effects of Ach on ANS
-onset= 30-45 mins
administered with inhaler/nebuliser
Implications of anticholinergics for PT
-dry mouth which can make expectoration of secretions more difficult
-unpleasant taste in mouth
Xanthines
-brochodilates, reduce inflammation, boost immunity, improve gas exchange and lung function
-administered with IV/tablets
Implications of Xanthines for PT
-Immediate side effects- headache, nausea and vomiting, cardiac arrhythmias and tachycardia
-Long term side effects- gastric ulcer formation and insomnia
-Unpleasant taste in mouth
Drugs that facilitate secretion clearance
Mucolytics
mobilises secretions to allow for clearance
Mucolytics
-Normal saline (0.9% NaCl) humidifies mucocilia and enhance clearance of viscous secretion (no side effects)
-Mistabron/Mesna thins secretion, dilute saline (1:3). may cause bronchoconstriction.
-Hypertonic saline (3-5% NaCl) for sputum induction or clear thick secretion in cystic fibrosis
-pulmozyme is use once every 24hrs for pts with cystic fibrosis
-carbocisteine
-ACC-200 is an effervescent tablet that clear secretion (taken with water)
- all above except ACC-200 administered via nebuliser
Implications of mucolytics for PT
-Hypertonic saline increase brochospasm in prone patients
-Carbocisteine cause gastro-intestinal bleeding over time